Background: Malignant middle cerebral artery (MCA) syndrome is a complication of ischaemic stroke. Untreated, mortality is up to 80%. A meta-analysis showed that decompressive craniectomy (DC) improves survival (OR 0.19. 95% CI:0.1-.37) but functional outcomes vary [1]. This case series aims to examine the Irish experience of DC for malignant MCA syndrome. Methods: This series reviewed cases in an Irish neurosurgical referral centre. It receives nationwide referrals and represents a significant proportion of DC performed in Ireland. Operating theatre logbooks for the years 2009-2014 were reviewed. Patients who underwent a DC for the treatment of malignant MCA syndrome were included. Medical records were reviewed to assess 6 month mortality rates. Functional outcome was measured by modified Rankin Scale (mRS) at 1 and 6 months post-operatively. Results: 23 patients were included with a mean age of 52.8 ± 11.8 years(44% female). 8 patients were aged over 60 years(mean 64.9 ± 2.9 years). 74%(n = 17) of strokes involved the right MCA. Referrals were received from 12 hospitals, with 26%(n = 6) of cases referred from within the centre where this case series was performed. The mean premorbid mRS was 0. The median time from symptom onset to surgery was 48 hours (range = 23-240 hours). The 6 month mortality rate was 17.4%(n = 4). Complete data on functional recovery was available for 21 patients. The mean mRS 1 month post procedure was 5 ± 0.63(n = 21). The mean 6 month mRS was 4.4 ± 0.92(n = 21). 56.5%(n = 13) of patients were living at home 6 months post-stroke. Conclusions: DC reduces mortality in malignant MCA syndrome and has been available in Ireland for many years. Our results show that patients who underwent surgery had low mortality rates but significant disability as measured by the mRS. Reference 1. Back L. et al. Role of decompressive hemicraniectomy in extensive middle cerebral artery strokes: a meta-analysis of randomised trials. Intern Med J 2015; 45(7):711-7.
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